<span class="vcard">John Joseph</span>
John Joseph

Evaluation of the Clear Fear Smartphone App for Young People Experiencing Anxiety: Uncontrolled Pre- and Post-Follow-Up Study

JMIR Form Res. 2025 Feb 28;9:e55603. doi: 10.2196/55603. ABSTRACT BACKGROUND: Mobile health apps are proving to be an important tool for increasing access to psychological …

Assessing Short-Video Dependence for e-Mental Health: Development and Validation Study of the Short-Video Dependence Scale

J Med Internet Res. 2025 Mar 4;27:e66341. doi: 10.2196/66341. ABSTRACT BACKGROUND: Short-video dependence (SVD) has become a significant mental health issue around the world. The …

The Effect of Predicted Compliance With a Web-Based Intervention for Anxiety and Depression Among Latin American University Students: Randomized Controlled Trial

JMIR Ment Health. 2025 Feb 28;12:e64251. doi: 10.2196/64251. ABSTRACT BACKGROUND: Web-based cognitive behavioral therapy (wb-CBT) is a scalable way to reach distressed university students. Guided …

Building consensus regarding the definition of abnormal craniocervical motion in pediatric patients with Chiari malformation: a modified Delphi study

J Neurosurg Pediatr. 2025 Mar 7:1-11. doi: 10.3171/2024.11.PEDS24478. Online ahead of print. ABSTRACT OBJECTIVE: Abnormal craniocervical motion (ACCM) in the setting of pediatric Chiari type …

Intrainfusion Drug Monitoring and Algorithm-Based Dose Adjustments for Children With ALL Receiving High-Dose Methotrexate Are Feasible and Safe in Costa Rica, a Low- and Middle-Income Country

JCO Glob Oncol. 2025 Mar;11:e2400450. doi: 10.1200/GO-24-00450. Epub 2025 Mar 7. ABSTRACT PURPOSE: Infusions of high-dose methotrexate at 5 g/m2 over 24 (HDMTX) as a …

Prospective Evaluation of the Pathologic Diagnosis and Treatment Outcomes of Pediatric Burkitt Lymphoma in the Central American Pediatric Hematology-Oncology Association Consortium

JCO Glob Oncol. 2025 Mar;11:e2400491. doi: 10.1200/GO-24-00491. Epub 2025 Mar 7. ABSTRACT PURPOSE: Clinical and histopathologic diagnosis of pediatric mature B-cell lymphomas (eg, Burkitt lymphoma …

Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study

Blood. 2025 Mar 7:blood.2024027008. doi: 10.1182/blood.2024027008. Online ahead of print. ABSTRACT Fitusiran, a subcutaneous investigational siRNA therapeutic, lowers antithrombin (AT) to increase thrombin generation and …